HIPO Insider Sale: CEO McCathron Disposes 10,759 Shares at $30.91
Rhea-AI Filing Summary
Richard McCathron, Chief Executive Officer and Director of Hippo Holdings Inc. (HIPO), reported an open-market sale of 10,759 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the reported disposition, McCathron beneficially owned 475,388 shares, which the filing notes includes 212,464 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses the transaction and the remaining stake but does not provide context such as whether the sale was pursuant to a pre-arranged trading plan or for personal reasons.
Positive
- Timely disclosure of insider transaction via Form 4, filed and signed by attorney-in-fact
- Substantial retained stake: reporting person beneficially owns 475,388 shares including 212,464 RSUs
Negative
- Insider disposition of 10,759 shares on 08/15/2025 at $30.91 per share
- No stated 10b5-1 plan or rationale is included in the filing, so the reason for the sale is not disclosed
Insights
TL;DR: Insider sale of 10,759 shares is disclosed; remaining stake of 475,388 shares includes substantial RSUs.
The reported sale on 08/15/2025 at $30.91 per share reduces the CEO's direct holdings but leaves a sizeable beneficial position of 475,388 shares including 212,464 RSUs. From a liquidity and signaling perspective, the Form 4 documents transparency around insider activity. The filing does not state a 10b5-1 plan or other pre-arrangement, so readers cannot determine whether the sale was routine diversification or opportunistic. No derivative transactions or additional disposals are reported.
TL;DR: Timely Form 4 filing shows compliance; sale noted but governance implications depend on undisclosed context.
The Form 4 was filed by a single reporting person and signed by an attorney-in-fact, indicating proper procedural handling. The report lists the CEO also as a director and confirms both direct ownership and RSU holdings. Absent disclosure of a trading plan or the proportional size of the sale relative to total holdings, governance interpretation remains neutral: the company complied with Section 16 reporting but did not provide explanatory context in the filing itself.
FAQ
What did Hippo Holdings CEO Richard McCathron report on Form 4 (HIPO)?
When was the Form 4 for HIPO filed and who signed it?
Does the Form 4 state if the sale was under a 10b5-1 trading plan?
How many RSUs are included in Richard McCathron's beneficial ownership?
Was any derivative security reported in this Form 4 for HIPO?